Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.

× No keyword cloud information.

15 in total

1. CALCIUM DYNAMICS OF THE GASTROINTESTINAL TRACT AND BONE IN PRIMARY HYPERPARATHYROIDISM.

Authors: J ANDERSON; S B OSBORN; R W TOMLINSON; M WALL
Journal: Q J Med Date: 1964-10

Review 2. PAGET'S DISEASE OF BONE: CLINICAL AND METABOLIC OBSERVATIONS.

Authors: C N DE DEUXCHAISNES; S M KRANE
Journal: Medicine (Baltimore) Date: 1964-05 Impact factor: 1.889

3. Plasma alkaline phosphatase in disease.

Authors: E J KING
Journal: Br Med Bull Date: 1953 Impact factor: 4.291

4. Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy.

Authors: W M Sy; A K Mittal
Journal: Br J Radiol Date: 1975-11 Impact factor: 3.039

5. Technetium-99m-pyrophosphate bone scans in hyperparathyroidism.

Authors: T Wiegmann; L Rosenthall; M Kaye
Journal: J Nucl Med Date: 1977-03 Impact factor: 10.057

6. Uptake by bone of pyrophosphate, diphosphonates and their technetium derivatives.

Authors: S Bisaz; A Jung; H Fleisch
Journal: Clin Sci Mol Med Date: 1978-03

7. Optimization of the ratio of stannous tin: ethane-1-hydroxy-1, 1-diphosphonate for bone scanning with 99mTc-pertechnetate.

Authors: A J Tofe; M D Francis
Journal: J Nucl Med Date: 1974-02 Impact factor: 10.057

8. The role of bone scanning in osteomalacia.

Authors: I Fogelman; J H McKillop; R G Bessent; I T Boyle; J G Turner; W R Greig
Journal: J Nucl Med Date: 1978-03 Impact factor: 10.057

9. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.

Authors: G Subramanian; J G McAfee; R J Blair; F A Kallfelz; F D Thomas
Journal: J Nucl Med Date: 1975-08 Impact factor: 10.057

10. Factors affecting uptake and retention of technetium-99m-diphosphonate and 99m-pertechnetate in osseous, connective and soft tissues.

Authors: M D Francis; C L Slough; A J Tofe
Journal: Calcif Tissue Res Date: 1976-06-14

15 in total

1. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.

Authors: L Hyldstrup; P McNair; P Ring; O Henriksen
Journal: Eur J Nucl Med Date: 1987

2. Isotope retention for assessment of bone turnover in involutional osteoporosis.

Authors: M Passeri; E Palummeri; M C Baroni; F Quaini; A Quintavalla; M Barbagallo; D Franchini; D Ugolotti
Journal: Clin Rheumatol Date: 1989-06 Impact factor: 2.980

3. 99mTc-MDP retention in osteoporosis: relationship to other indices of bone cell activity and response to calcium and vitamin D therapy.

Authors: M W Davie; J M Britton; M Haddaway; I W McCall
Journal: Eur J Nucl Med Date: 1987

4. Accuracy of 24-h whole-body (skeletal) retention of diphosphonate measurements.

Authors: I Fogelman; R Bessent; J E Scullion; G F Cuthbert
Journal: Eur J Nucl Med Date: 1982

5. A comment on "Kinetics of 99mTc-tin-methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism".

Authors: A Caniggia; A Vattimo
Journal: Calcif Tissue Int Date: 1983 Impact factor: 4.333

10. 25-Hydroxycholecalciferol as an antagonist of adverse corticosteroid effects on phosphate and calcium metabolism in man.

Authors: R Nuti; A Vattimo; V Turchetti; G Righi
Journal: J Endocrinol Invest Date: 1984-10 Impact factor: 4.256

Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.